Deng Liu

Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small Cell Lung Cancer.

Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 04, 2026

Annexin A1 enhances liver repair after acetaminophen-induced liver injury by regulating neutrophils function.

Annexin A1 enhances liver repair after acetaminophen-induced liver injury by regulating neutrophils function.

Journal: Free radical biology & medicine

Published: December 27, 2025

Effects of Dexmedetomidine on Postoperative Quality of Recovery and Electroencephalogram in Elderly Patients Undergoing Total Knee Arthroplasty: A Randomized Clinical Trial.

Effects of Dexmedetomidine on Postoperative Quality of Recovery and Electroencephalogram in Elderly Patients Undergoing Total Knee Arthroplasty: A Randomized Clinical Trial.

Journal: Drug design, development and therapy

Published: April 23, 2025

AXL activation governs the liver microenvironment to protect ischemia-reperfusion injury by suppressing NLRP3 inflammasome.

AXL activation governs the liver microenvironment to protect ischemia-reperfusion injury by suppressing NLRP3 inflammasome.

Journal: Cellular & molecular biology letters

Published: April 10, 2025

S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker.

S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker.

Journal: Frontiers in oncology

Published: March 08, 2025

Taxifolin attenuates hepatic ischemia-reperfusion injury by enhancing PINK1/Parkin-mediated mitophagy.

Taxifolin attenuates hepatic ischemia-reperfusion injury by enhancing PINK1/Parkin-mediated mitophagy.

Journal: European journal of pharmacology

Published: July 11, 2024

Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.

Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.

Journal: Transplantation

Published: May 10, 2024

Protozoan-Derived Cytokine-Transgenic Macrophages Reverse Hepatic Fibrosis.

Protozoan-Derived Cytokine-Transgenic Macrophages Reverse Hepatic Fibrosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 15, 2023

Piceatannol alleviates liver ischaemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 in hepatic macrophages.

Piceatannol alleviates liver ischaemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 in hepatic macrophages.

Journal: European journal of pharmacology

Published: July 18, 2023

Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma.

Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma.

Journal: Functional & integrative genomics

Published: December 25, 2022

miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.

miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.

Journal: Digestive diseases and sciences

Published: November 09, 2022

Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression.

Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression.

Journal: Transplantation

Published: May 12, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026